KOPP FAMILY OFFICE, LLC Holdings

KOPP FAMILY OFFICE, LLC is an investment fund managing more than 122.85M US dollars. The largest holdings include Horizon Therapeutics Public Limited Company, ISHARES TR and Jamf Holding Corp.. In Q3 2022 the fund bought assets of total value of -4.33M US dollars and sold assets of total value of 15.16M US dollars.

$122.85M

portfolio value

-13.22%

quarter

-57.45%

1 year

KOPP FAMILY OFFICE, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2020	5404000	13075000
Q2 2020	45569000	13000
Q3 2020	23955000	25158000
Q4 2020	-1240000	45460000
Q1 2021	44045000	63378000
Q2 2021	34118000	18432000
Q3 2021	9568000	774000
Q4 2021	13380000	36624000
Q1 2022	-41817000	1808000
Q2 2022	-26753000	15911000
Q3 2022	-4331000	15160000

KOPP FAMILY OFFICE, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Drug Manufacturers—General Horizon Therapeutics Public Limited Company Portfolio share: 27.33% Portfolio value: 33.57M Avg. open price: $66.33 Current price: $98.48 P/L: +48.47% Sold -0.28% shares Q3 2022	share	27.33%	33.57M	$66.33	$98.48	+48.47%	Sold -0.28% shares Q3 2022
ISHARES TR Portfolio share: 16.72% Portfolio value: 20.53M Avg. open price: N/A Current price: N/A P/L: N/A Sold -0.20% shares Q3 2022	share	16.72%	20.53M	N/A	N/A	N/A	Sold -0.20% shares Q3 2022
Software—Application Jamf Holding Corp. Portfolio share: 11.25% Portfolio value: 13.81M Avg. open price: $34.51 Current price: $20.79 P/L: -39.75% Bought +0.35% shares Q3 2022	share	11.25%	13.81M	$34.51	$20.79	-39.75%	Bought +0.35% shares Q3 2022
Diagnostics & Research NeoGenomics, Inc. Portfolio share: 10.79% Portfolio value: 13.25M Avg. open price: $26.49 Current price: $11.8 P/L: -55.45% Sold -4.73% shares Q3 2022	share	10.79%	13.25M	$26.49	$11.8	-55.45%	Sold -4.73% shares Q3 2022
Software—Infrastructure Five9, Inc. Portfolio share: 10.69% Portfolio value: 13.13M Avg. open price: $132.38 Current price: $66.22 P/L: -49.98% Bought +0.40% shares Q3 2022	share	10.69%	13.13M	$132.38	$66.22	-49.98%	Bought +0.40% shares Q3 2022
iShares Core MSCI Emerging Markets ETF Portfolio share: 10.64% Portfolio value: 13.07M Avg. open price: $62.15 Current price: $48.11 P/L: -22.59% Sold -0.20% shares Q3 2022	share	10.64%	13.07M	$62.15	$48.11	-22.59%	Sold -0.20% shares Q3 2022
Biotechnology Vericel Corporation Portfolio share: 10.44% Portfolio value: 12.82M Avg. open price: $15.15 Current price: $22.7 P/L: +49.86% Sold -0.00% shares Q3 2022	share	10.44%	12.82M	$15.15	$22.7	+49.86%	Sold -0.00% shares Q3 2022
Software—Application Mitek Systems, Inc. Portfolio share: 1.90% Portfolio value: 2.32M Avg. open price: $17.97 Current price: $10.44 P/L: -41.91% Bought +1.27% shares Q3 2022	share	1.90%	2.32M	$17.97	$10.44	-41.91%	Bought +1.27% shares Q3 2022
iShares Core 1-5 Year USD Bond ETF Portfolio share: 0.08% Portfolio value: 103K Avg. open price: $50.85 Current price: $46.56 P/L: -8.43% Bought +8.68% shares Q4 2021	share	0.08%	103K	$50.85	$46.56	-8.43%	Bought +8.68% shares Q4 2021
iShares Core S&P 500 ETF Portfolio share: 0.07% Portfolio value: 84K Avg. open price: N/A Current price: $401.35 P/L: N/A Sold -19.86% shares Q4 2021	share	0.07%	84K	N/A	$401.35	N/A	Sold -19.86% shares Q4 2021
ISHARES TR Portfolio share: 0.03% Portfolio value: 42K Avg. open price: N/A Current price: N/A P/L: N/A Bought +10.09% shares Q4 2021	share	0.03%	42K	N/A	N/A	N/A	Bought +10.09% shares Q4 2021
iShares Core 5-10 Year USD Bond ETF Portfolio share: 0.03% Portfolio value: 35K Avg. open price: $50.54 Current price: $43.4 P/L: -14.13% Bought +9.16% shares Q4 2021	share	0.03%	35K	$50.54	$43.4	-14.13%	Bought +9.16% shares Q4 2021
iShares Core S&P Mid-Cap ETF Portfolio share: 0.02% Portfolio value: 27K Avg. open price: N/A Current price: $250.71 P/L: N/A Sold -17.01% shares Q4 2021	share	0.02%	27K	N/A	$250.71	N/A	Sold -17.01% shares Q4 2021
iShares Core S&P Small-Cap ETF Portfolio share: 0.01% Portfolio value: 15K Avg. open price: N/A Current price: $99.28 P/L: N/A Sold -18.36% shares Q4 2021	share	0.01%	15K	N/A	$99.28	N/A	Sold -18.36% shares Q4 2021

Showing TOP 14 KOPP FAMILY OFFICE's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of KOPP FAMILY OFFICE, LLC?

The biggest position of the KOPP FAMILY OFFICE, LLC is Horizon Therapeutics Public Limited Company (HZNP) with 27.33% portfolio share worth of 33.58M US dollars.

Top 5 KOPP FAMILY OFFICE's holdings represent 76.77% of the portfolio:

Horizon Therapeutics Public Limited Company (HZNP) – 27.33%
ISHARES TR () – 16.72%
Jamf Holding Corp. (JAMF) – 11.25%
NeoGenomics, Inc. (NEO) – 10.79%
Five9, Inc. (FIVN) – 10.69%

Who is the portfolio manager of KOPP FAMILY OFFICE, LLC?

The portfolio manager of the KOPP FAMILY OFFICE, LLC is .

What is the total asset value of the KOPP FAMILY OFFICE, LLC portfolio?

KOPP FAMILY OFFICE, LLC total asset value (portfolio value) is 122.85M US dollars.

Who is ?

is the portfolio manager of the KOPP FAMILY OFFICE, LLC.

What is (KOPP FAMILY OFFICE, LLC) fund performance?

KOPP FAMILY OFFICE's quarterly performance is -13.22%, annualy -57.45%.

What is the KOPP FAMILY OFFICE, LLC CIK?

KOPP FAMILY OFFICE's Central Index Key is 0001683689 .